Healthcare professionals use the Luteinizing Hormone baseline test to assess the effect of baseline serum luteinizing hormone levels on follicular development, ovulation, conception, and pregnancy outcome in the case of infertile patients with PCOS. It also has a certain diagnostic value for central precocious puberty (CPP) at distinct bone ages and may be employed as a monitoring index during treatment and follow-up.